Wavemaker Three-Sixty Health

Wavemaker Three-Sixty Health (also known as Wavemaker 360) is the leading U.S. early-stage venture capital fund focused exclusively on healthcare. Since its founding in 2018, it has invested in over 50 companies across health-tech, digital health, medical devices, telehealth, artificial intelligence for healthcare, pharma-tech and related marketplaces. The fund’s portfolio valuation exceeds $2.5 billion and it has deployed more than $20 million into startups that are transforming healthcare delivery and outcomes.

The firm’s limited partners are predominantly experienced healthcare industry professionals from payers, providers (across the continuum of care), and pharma sectors—providing unique value-add to their portfolio companies. Wavemaker focuses on seed-stage investments primarily in North America but also supports select opportunities globally.

As a venture capital firm rather than an operating biotech or medtech company itself, it does not have its own clinical pipeline or therapeutic programs.